NAVIFUS CORPORATION
Update：2023/06/12
Industries
Main Industry
Health Care
Main Product/Service
1. NaviFUSR Neuronavigator-guided transcranial focused ultrasound system
2. NAVIRFAR Needle Tracking System
2. NAVIRFAR Needle Tracking System
Founded Year
2015
Unified Business No.
24731239
Status
Active
Number of Employees
0
Total Paid-in
Capital
707,400,110 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2022)、OTC listing(2025)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
As a biotech company, NaviFUS provides novel platform solutions for enhancing the delivery of oncology drugs across the blood-brain barrier. The company's product NaviFUS System utilizes non-invasive ultrasound energy, the NaviFUS System increases BBB permeability transiently and safely, facilitating targeted delivery of small or largemolecular CNS drugs. The company's focus is on helping CNS disease patients globally by supplying therapeutic ultrasound technologies for clinical use through partnerships with global pharmaceutical companies.
